anti cancer new program
TRANSCRIPT
![Page 1: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/1.jpg)
![Page 2: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/2.jpg)
CANCERCANCER• is a disease in which there in
uncontrolled multiplication & spread within the body of abnormal forms of the body’s own cells.
![Page 3: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/3.jpg)
Special Characteristics of Special Characteristics of Cancer CellsCancer Cells
• Uncontrolled Proliferation
• Dedifferentiation and loss of function
• Invasiveness
• Metastasis
![Page 4: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/4.jpg)
Management of CancerManagement of Cancer
• Surgical
• Irradiation
• Chemotherapy
![Page 5: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/5.jpg)
PHASES OF CELL PHASES OF CELL CYCLECYCLE
![Page 6: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/6.jpg)
Mitosis
M
Synthetic
S
Pre-
Synthetic
G1
Pos
t –S
ynth
etic
G2
DIFFEREN-TIATION
G0
![Page 7: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/7.jpg)
Cell Cycle Non – Specific (CCNS) Cell Cycle Non – Specific (CCNS) AgentsAgents
ALKYLATING
AGENTS• Busulfan• Carmustine• Cyclophosphamide• Lomustine• Mechlorethamine• Melphalan• Thiothepa
ANTHRACYCLINES• Daunorubicin• Doxorubicin• Epirubicin• Idarubicin• Mitoxantrone
ANTI TUMOR
ANTIBIOTICS• Dactinomycin• Mitomycin
CAMPTOTHECINS
• Irinotecan
• Topotecan
PLATINUM ANALOGS
• Carboplatin
• Cisplatin
• Oxaliplatin
![Page 8: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/8.jpg)
Cell Cycle Specific (CCS) AgentsCell Cycle Specific (CCS) Agents
ANTIMETABOLITES• Capecitabine• Cladribine• Cytarabine• Fluorouracil• Gemcitabine• Mercaptopurine• Methotrexate• Thioguanine
ANTITUMOR ANTIBIOTIC
• BleomycinEPIPODOPHYLLO-TOXINS• Etoposide• Teniposide• TAXANES• Docetaxel• Paclitaxel
VINCA ALKALOIDS
• Vinblastine
• Vincristine
• Vinorelbine
![Page 9: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/9.jpg)
• CCS:
• Hematological malignancies,
• solid tumors in growth fraction
CCNS:
• low groth fraction solid tumors
• high growth fraction tumors
![Page 10: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/10.jpg)
CANCER CHEMOTHERAPEUTIC CANCER CHEMOTHERAPEUTIC AGENTSAGENTS
C. CYTOTOXIC ANTIBIOTICS
• microbial in origin
• prevent cell division
D. PLANT DERIVATIVES
• affect microtubules and formation of mitotic spindle
![Page 11: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/11.jpg)
![Page 12: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/12.jpg)
![Page 13: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/13.jpg)
CANCER CHEMOTHERAPEUTIC CANCER CHEMOTHERAPEUTIC AGENTSAGENTS
II. HORMONES• suppress hormone secretion
• antagonize hormone action
III. MISCELLANEOUS AGENTS
![Page 14: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/14.jpg)
CLASSIFICATION OF CLASSIFICATION OF ANTI-CANCER ANTI-CANCER
DRUGSDRUGS
![Page 15: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/15.jpg)
POLYFUNCTIONAL ALKYLATING POLYFUNCTIONAL ALKYLATING AGENTSAGENTS
A. NITROGEN MUSTARD
1. CYCLOPHOPHAMIDE
2. CHLORAMBUCIL
3. MECHLORETHAMINE
4. IFOSFAMIDE
5. MELPHALAN
6. ESTRAMUSTINE
B. NITROSOUREA
1. CARMUSTINE(BNCU)
2. SEMUSTINE (methyl CCNU)
3.LOMUSTINE( CCNU)
4.STREPTOZOCIN
![Page 16: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/16.jpg)
POLYFUNCTIONAL ALKYLATING POLYFUNCTIONAL ALKYLATING AGENTSAGENTS
C.ALKYL SULFONATE1. BUSULFAN
D.AZIRIDINE 1. THIOTEPA
E. TREOSULPHAN
![Page 17: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/17.jpg)
RELATED DRUGS PROBABLY RELATED DRUGS PROBABLY ACTING AS ALKYLATING AGENTSACTING AS ALKYLATING AGENTS
1. PROCARBAZINE
2. CISPLATIN
3. DACARBAZINE
4. CARBOPLATIN
5. ALTRETAMINE
![Page 18: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/18.jpg)
ANTIMETABOLITESANTIMETABOLITESA. FOLATE ANTAGONIST
1. METHOTREXATE
B. PURINE ANTAGONIST1. MERCAPTOPURINE 4. FLUDARABINE
2. THIOGUANINE 5. PENTOSTATIN
3. CLADRIBINE
C. PYRIMIDINE ANTAGONIST1. FLUOROURACIL 3. CYTARABINE
2. CAPECITABINE 4. GEMCITABINE
![Page 19: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/19.jpg)
PLANT ALKALOIDSPLANT ALKALOIDS1. VINBLASTINE
2. VINCRISTINE
3. VINORELBINE
4. PODOPHYLLOTOXINS (ETOPOSIDE & TENIPOSIDE)
5. CAMPTOTHECINS (TOPOTECAN & IRINOTECAN)
6. TAXANES (PACLITAXEL & DOCETAXEL)
![Page 20: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/20.jpg)
ANTIBIOTICSANTIBIOTICS1. ANTHRACYCLINES(DOXORUBICIN &
DAUNORUBICIN)
2. DACTINOMYCIN(ACTINOMYCIN D)
3. PLICAMYCIN(METHRAMYCIN
4. MITOMYCIN (MITOMYCIN C)
5. BLEOMYCIN
6. EPIRUBICIN
7. MITOZANTRONE
![Page 21: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/21.jpg)
HORMONAL AGENTSHORMONAL AGENTSA. ADRENOCORTICOIDS
1. PREDNISONE2. HYDROCORTISONE
B. ANDROGENS1. TESTOSTERONE2.FLUOXYMESTERONE
C. ESTROGENS1. DIETHYLSTILBESTROL2. ETHINYL ESTRADIOL
D. PROGESTINS1. HYDROXYPROGESTERONE2.MEDROXYPROGESTERONE
![Page 22: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/22.jpg)
HORMONAL AGENTSHORMONAL AGENTS
E. ESTROGEN INHIBITOR :
1. TAMOXIFEN
2. TORIMIFENE
F. ANDROGEN INHIBITOR
1. FLUTAMIDE
2.CYPROTERONE
![Page 23: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/23.jpg)
HORMONAL AGENTSHORMONAL AGENTSG. GONADOTROPIC RELEASING HORMONE
AGONIST (GnRH)
1. LEUPROLIDE 2. GOSERELIN3. NAFERELIN
H. AROMATASE INHIBITORS1. AMINOGLUTETHIMIDE & TRILOSTANE2. ANASTROZOLE3. LETROZOLE4.EXEMESTANE
![Page 24: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/24.jpg)
MISCELLANEOUS ANTI - CANCER DRUGSMISCELLANEOUS ANTI - CANCER DRUGS1. IMATINIB2. GROWTH FACATOR RECEPTOR
INHIBITORA. CEFUXIMAB
B. GEFITINIB & ERLOTINIB C. BEVACIZUMAB 3. ASPARAGINASE (CRISANTASPASE)4. HYDROXYUREA5. RETINOIC ACID DERIVATIVE (TRETINOIN)6. ARSENIC TRIOXIDE
![Page 25: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/25.jpg)
MISCELLANEOUS ANTI - CANCER MISCELLANEOUS ANTI - CANCER DRUGSDRUGS
6. BONE MARROW GROWTH FACTORS
• GRANULOCYTE COLONY-STIMULATING FACTOR
(G-CSF, FILGRASTIM)
• GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF, SARGAMOSTIM)
• AMI FOSTINE (ETHYOL)
![Page 26: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/26.jpg)
MISCELLANEOUS ANTI - CANCER DRUGSMISCELLANEOUS ANTI - CANCER DRUGS
• MONOCLONAL ANTIBODIES1. RIFUXIMAB2. TRASTUZUMAB
• RADIOACTIVE ISOTOPES• RADIOACTIVE IODINE-TREATMENT OF
THYROID CABIOLOGICAL RESPONSE MODIFIER
* INTERFERONS, ALDESLEUKIN, TRETINOIN
![Page 27: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/27.jpg)
![Page 28: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/28.jpg)
ALKYLATING AGENTSI. PHARMACOKINETICS
– oral or parenteral administration– hepatic microsome P450 mediated
cyclophosphamide ACROLEIN…….MESNA
–nitrosoureas: highly lipid soluble–unchanged form in urine (cisplatin)–terminated via hepatic metabolism:
procarbazine
![Page 29: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/29.jpg)
II. PHARMACODYNAMICS OF ALKYLATING AGENTS
CCNS: Form reactive molecules…> alkylation (N7 guanine)………>
Cross linking of bases abnormal base pairing & DNA strand breakage
RESISTANCE THRU:↑ DNA repair / ↓ drug permeabilityproduction of trapping agents
![Page 30: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/30.jpg)
ALKYLATING AGENTSIII. CLINICAL INDICATIONS
A. CYCLOPHOSPHAMIDE: non Hodgskin’s lymphoma, breast
& ovarian CA, neuroblastomaB. MECHLORETHAMINE: Hodgskin ‘s disease (MOPP)C. CARMUSTINE & LOMUSTINE: brain tumorsD. BUSULFAN: chronic myelogenous leukemia /Thiotepa: ovarian ca
![Page 31: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/31.jpg)
IV. ADVERSE EFFECTS OF ALKYLATING AGENTS
• NAUSEA & VOMITING Myelosuppression
• hemorrhagic cystitis (cyclophosphamide)
• peripheral neuropathy (altretamine))• adrenal insufficiency, pulmonary
fibrosis & skin pigmentation (busulfan)
![Page 32: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/32.jpg)
RELATED DRUGS PROBABLY ACTING RELATED DRUGS PROBABLY ACTING AS ALKYLATING AGENTSAS ALKYLATING AGENTS
A. PROCARBAZINE• in Hodgkin’s lymphoma• leukemogenic, teratogenic,
mutagenic• N & V, myelosuppression, hemolytic
anemia, pulmonary reaction, disulfiram like effect, skin rashes, CNS depression
![Page 33: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/33.jpg)
B.CISPLATIN:
–inorganic metal complex
–In testicular CA, bladder, lung & ovarian CA
–Nausea, vomiting, myelosuppression
–Nephrotoxicity, neurotoxocity, ototoxicity, anaphylaxis
![Page 34: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/34.jpg)
![Page 35: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/35.jpg)
.METHOTREXATEPHARMACODYNAMICS• Inhibits dihydrofolate reductase…………..>• INTERFERES w/ thymidylate & purine
nucleotide , serine, methionine• …> DNA synthesis & cell division blockRESISTANCE:• 1. ↓ drug accumulation• 2.change in drug sensitivity or activity of
dihydrofolate reductase• 3. ↓ formation of polyglutamates
![Page 36: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/36.jpg)
METHOTREXATEMETHOTREXATEPHARMACOKINETICS: Oral, IV. IM, intrathecal CLINICAL USE: choriocarcinoma, acute
leukemias, nonHodgskins and cutaneous T cell lymphomas, breast CA; rheumatoid arthritis, psoriasis & abortifacient
ADVERSE EFFECTS; N & V & D, mucositis• myelosuppression ; skin effects• reduced by folinic acid (leukoverin rescue)• enhance by salicylates, NSAID, sulfonamides,
sulfonylureas
![Page 37: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/37.jpg)
MERCAPTOPURINE (6 MP) & MERCAPTOPURINE (6 MP) & THIOGUANINE (6 TG)THIOGUANINE (6 TG)
• 6 THIOINOSINIC ACID….activated by hypoxanthine - guanine phosphoribosyltransferase (HGPRT)….>
• inhibit enzymes involved in purine metabolism
RESISTANCE:• decrease HGPRT activity
• increase alkaline phosphatases that inactivate the toxic nucleotides
![Page 38: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/38.jpg)
MERCAPTOPURINE (6 MP) & MERCAPTOPURINE (6 MP) & THIOGUANINE (6 TG)THIOGUANINE (6 TG)
PHARMACOKINETCS: oral; urine• 6MP metabolism inhibited by allopurinol
CLINICAL INDICATIONS• acute leukemias ; chronic myelocytic leukemias
ADVERSE EFFECTS:• myelosuppression, immunosuppression,
hepatotoxicity
![Page 39: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/39.jpg)
FLUOROURACIL ( 5FU)FLUOROURACIL ( 5FU)• Uracil, interferes with DTMP
• ( 5 FDUMP)………..> thymidylate synthase….> “thymineless death” 5FdUTP….> DNA synthesis inhibition
RESISTANCE:
– decreased activation of 5 FU
– increased thymidylate synthase activity
– reduce drug sensitivity of this enzyme
![Page 40: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/40.jpg)
FLUOROURACIL ( 5FU)FLUOROURACIL ( 5FU)
PHARMACOKINETICS : IV• widely distributed; hepatic metabolism
CLINICAL USES: colorectal, stomach, pancreas, esophagus, liver, bladder, breast, head and neck, liver & ovarian cancers
• topical: keratoses & basal cell cancer
ADVERSE EFFECTS: myelosuppression, GIT effects & alopecia, hand & foot syndrome, neurotoxicity
![Page 41: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/41.jpg)
CYTARABINE (ARA-C)CYTARABINE (ARA-C)
• activated to Ara CTP (inhibitor of DNA polymerase)
• most S specific
RESISTANCE
• ↓ uptake / ↓ conversion to Ara CTP
CLINICAL USE: acute leukemias
ADVERSE EFFECTS: myelosuppression & GIT irritation; neurotoxicity & peripheral neuritis
![Page 42: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/42.jpg)
![Page 43: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/43.jpg)
A. VINBLASTINE & VINCRISTINE* Periwinkle plant
– spindle poisons– prevent assembly of tubulin dimmers
into microtubules– block formation of mitotic spindle– act on M phase– RESISTANCE: increase efflux of the drug
PHARMACOKINETICS• Parenterally• Hepatic metabolism
![Page 44: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/44.jpg)
A. VINBLASTINE & VINCRISTINEA. VINBLASTINE & VINCRISTINECLINICAL USE
VINCRISTINE: MOPP & COP; acute leukemias, lymphomas, wilm’s tumor, choriocarcinomaVINBLASTINE: ABVD; other lymphomas, neuroblastoma, testicular cancer, Kaposi’s sarcomaVINORELBINE: advance non- small cell cancer
ADVERSE EFFECTS:VINBLASTINE: GIT distress, alopecia, bone marrow
suppression, alopeciaVINCRISTINE: neurotoxicity, areflexia, peripheral
neuritis, paralytic ileus
![Page 45: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/45.jpg)
B. ETOPOSIDE & TENIPOSIDEB. ETOPOSIDE & TENIPOSIDE• Podophyllotoxins from May apple root
• interacts w/ topoisomerase II….>inhibits mitochondrial electron transport….> increase degradation of DNA
• late S and early G2 phase
• oral; elimination thru the kidneys
• small cell lung CA, prostate & testicular CA
• cause bone marrow suppression, GIT effects, alopecia
![Page 46: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/46.jpg)
C. TOPOTECAN & IRINOTECANC. TOPOTECAN & IRINOTECAN
• from Comptotheca acuminate tree
• inhibit topoisomerase I
• DNA damage
• Topotecan: advanced ovarian cancer, small cell lung cancer
• Irinotecan: ,metastatic colorectal CA
• Cause: myelosuppression & diarrhea
![Page 47: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/47.jpg)
D. PACLITAXEL & DOCETAXELD. PACLITAXEL & DOCETAXEL– Taxanes from Western yew
– Prevent microtubule disassembly into tubulin monomers; by IV
– Advanced breast and ovarian cancers
– Paclitaxel: N & V, myelosuppression, peripheral neuropathy, hypersensitivity rx
– Docetaxil: neurotoxicity & bone marrow suppression, fluid retention, rash
![Page 48: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/48.jpg)
ANTIBIOTICSANTIBIOTICS
![Page 49: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/49.jpg)
A. DOXORUBICIN & DAUNORUBICINA. DOXORUBICIN & DAUNORUBICIN
intercalate between base pairs………> inhibit topoisomerase II….>
generate free radicals …………> block synthesis of RNA & DNA…>
DNA strand scisisionGiven IV; excreted in the bile & urine
![Page 50: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/50.jpg)
A. DOXORUBICIN & DAUNORUBICINA. DOXORUBICIN & DAUNORUBICIN
DAUNORUBICIN: acute leukemiasDOXORUBICIN: ABVD; myelomas,
sarcomas, breast, endometrial, lungs, ovarian & thyroid cancers
CARDIOTOXICITY ( USE DEXRAZOXANE, radical scavenger)
Bone marrow suppression, GIT effects, alopecia
![Page 51: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/51.jpg)
B. BLEOMYCINB. BLEOMYCINDNA strand breakage …..……>
inhibit DNA synthesis CCS on G2 phaseUSE: testicular cancer & Hodgskin’s
lymphoma, lymphomas, squamous cell cancer
Hypersensitivity reaction, pulmonary dysfunction
![Page 52: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/52.jpg)
C. DACTINOMYCINC. DACTINOMYCINbinds to double-stranded DNA &
inhibits DNA dependent RNA synthesis
USE: melanoma & wilm’s tumorCauses bone marrow suppression,
skin & GIT irritation
![Page 53: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/53.jpg)
D. MITOMYCIND. MITOMYCIN
• Activated to form an alkylating agent…> cross links DNA
• IV given; hepatic metabolism
• USE: adenocarcinoma of the cervix, stomach, pancreas & lungs
• Causes myelosuppression
![Page 54: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/54.jpg)
![Page 55: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/55.jpg)
HORMONAL ANTICANCER HORMONAL ANTICANCER AGENTSAGENTS
A. GLUCOCORTICOIDS• Prednisone/ Hydrocortisone:• acute & chronic lymphocytic
leukemias, hodgskin’s disease, other lymphomas
• Fluid retention, hypertension, diabetes, Increase susceptibility to infection
![Page 56: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/56.jpg)
HORMONAL ANTICANCER HORMONAL ANTICANCER AGENTSAGENTS
B. SEX HORMONESestrogen, progestins, androgens:
hormone dependent cancers to change the hormone balance
Fluoxymesterone: advanced breast CADiethylstilbestrol: prostatic cancer
![Page 57: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/57.jpg)
HORMONAL ANTICANCER AGENTSHORMONAL ANTICANCER AGENTSC. SEX HORMONES ANTAGONISTS
– tamoxifen: estrogen receptor partial agonist
– may cause nausea & vomiting, hot flushes, vaginal bleeding, hypercalcemia, ocular, dysfunction& peripheral edema
– Flutamide: prostatic cancer– Cause:gynecomastia, hot flushes,
hepatic dysfunction
![Page 58: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/58.jpg)
HORMONAL ANTICANCER AGENTSHORMONAL ANTICANCER AGENTS
D. GONADOTROPIN-RELEASING HORMONE ANALOGS (GnRh ANALOG)–Leuprolide, Goserelin & nafarellin– inhibit release of pituitary LH & FSH–prostatic cancer–may cause: bone pain, gynecomastia,
hematuria, impotence & testicular atrophy
![Page 59: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/59.jpg)
HORMONAL ANTICANCER AGENTSHORMONAL ANTICANCER AGENTS
E. AROMATASE INHIBITORS–anastrozole & leterozole– inhibit enzyme that catalyzes the
conversion of androstenedione to estrone–advanced breast cancer–diarrhea, nausea, hot flushes, bone &
back pain, peripheral edema
![Page 60: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/60.jpg)
MISCELLANEOUS ANTICANCER
AGENTS
![Page 61: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/61.jpg)
MISCELLANEOUS ANTICANCER MISCELLANEOUS ANTICANCER AGENTSAGENTS
A. Asparaginase depletes serum asparagines used in leukemias & lymphomas given IV Cause severe hypersensitivity
reactions, neurotoxicity & bleeding
![Page 62: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/62.jpg)
MISCELLANEOUS ANTICANCER AGENTSMISCELLANEOUS ANTICANCER AGENTS
B. IMATINIBInhibitor of the tyrosine kinase
domain of the Bcr- Abl oncogenes & prevent the phosphorylation of the kinase substrate by ATP
For CML, GIT stromal tumorsN /V/D, Fluid Retention, Myalgia
![Page 63: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/63.jpg)
GROWTH FACTOR RECEPTOR GROWTH FACTOR RECEPTOR INHIBITORSINHIBITORS
• A. CEFUZIMAB
• Colorectal Ca
• B. GEFITINIB & ERLOTINIB
• NSCLCa
• C. BEVACIZUMAB
• Metastatic colororectal Ca
![Page 64: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/64.jpg)
MISCELLANEOUS ANTICANCER AGENTSMISCELLANEOUS ANTICANCER AGENTS
C. Interferons endogenous glycoproteins with
antineoplastic, immunosuppresion & antiviral actions
Use in hairy cell leukemias, chronic myelogenous leukemia, T cell lymphomas
Cause myelosuppression & neurologic dysfunction
![Page 65: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/65.jpg)
MISCELLANEOUS ANTICANCER AGENTSMISCELLANEOUS ANTICANCER AGENTS
D. Monoclonal AntibodiesRIFUXIMABMonoclonal antibody to a surface protein
non- Hodgskin’s lymphoma cellsTRASTUZUMAB: monoclonal antibody to a
surface protein in breast cancers that over express the HER2 protein
Toxicity: hypersensitivity reactions & myelosuppression
Cardiac dysfunction with trastuzumab
![Page 66: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/66.jpg)
STRATEGIES IN CANCER STRATEGIES IN CANCER CHEMOTHERAPYCHEMOTHERAPY
I. Each drug should be active when used alone against the particular cancer
II. The drug should have different mechanism of action
III. Cross resistant between drugs should be minimal.
IV. The drugs should have different toxic effects.
![Page 67: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/67.jpg)
SAMPLES OF COMBINATION SAMPLES OF COMBINATION CHEMOTHERAPYCHEMOTHERAPY
. HODGKIN’S DISEASE: MOPP / ABVD
2. NON-HODGKIN’S LYMPHOMA: COP
3. TESTICULAR CARCINOMA: PVB
4. BREAST CANCER: CMF/CAF
![Page 68: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/68.jpg)
CANCER CHEMOTHERAPY ACRONYMSCANCER CHEMOTHERAPY ACRONYMS• ABVD : Doxorubicin (adriamycin),
bleomycin, vinblastine, dacarbazine• CHOP :Cyclophosphamide, doxorubicin
(hydroxydaunorubicin), vincristine
(oncovin), Prednisone• MOPP : Melchlorethamine, vincristine
(oncovin), Procarbazine, Prednisone
![Page 69: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/69.jpg)
ACRONYMSACRONYMS• COP :Cyclophosphamide,
vincristine (oncovin), prednisone• PEB: Platinuml(cisplatin),• etoposide bleomycin• CMF : Cyclophosphamide,
methotrexate, Fluouracil• CAF: cyclophosphamide,
adriamycin(doxorubicin) , 5 FU
![Page 70: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/70.jpg)
THE LEUKEMIASTHE LEUKEMIAS
![Page 71: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/71.jpg)
1. ACUTE LEUKEMIA1. ACUTE LEUKEMIA
ALL: induction: vincristine & prednisone
>remission maintenance: mercaptopurine, methotrexate / cyclophosphamide
AML: cytarabine, mitoxantrone or daunorubicin or idarubicin
![Page 72: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/72.jpg)
2.CHRONIC LEUKEMIA2.CHRONIC LEUKEMIA
CML: Imatinib, busulfan, or interferon
bone marrow transplant CLL: chlorambucil & prednisone fludarabine
![Page 73: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/73.jpg)
THE LYMPHOMAS THE LYMPHOMAS 1. HODGKIN’S DISEASE
MOPP ABVD
2. NON-HODGKIN’S LYMPHOMA CHOP
MULTIPLE MYELOMA melphalan & prednisone
![Page 74: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/74.jpg)
CARCINOMA OF THE BREASTCARCINOMA OF THE BREAST
Stage I SURGERY
• Stage II: positive lymph nodes: SURGERY plus cytotoxic chemo in 6 cycles at one month apart; CMF/CAF; tamoxifen in postmenopausal women
• Trastazumab: HER-2/neu receptors
Stage III & IV Palliative
aminoglutethimide, trastuzumab
![Page 75: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/75.jpg)
CARCINOMA CARCINOMA WILM’S TUMOR: vincristine plus
dactinomycin after surgery & radiotherapy
NEUROBLASTOMA: doxorubicin + cyclophosphamide + vincrisitne
CARCINOMA OF THE PANCREAS: gemcitarabine
POLYCYTHEMIA VERA: busulfan, chlorambucil or cyclophosphamide
![Page 76: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/76.jpg)
CARCINOMACARCINOMACHORIOCARCINOMA OF THE UTERUS:
Methotrexate / Etoposide & Cisplatin
CARCINOMA OF THE OVARY: cisplatin & paclitaxel
TESTICULAR NEOPLASMS: PEB
CARCINOMA OF THE PROSTATEEstrogen, leuprolide & Flutamide
CARCINOMA OF THE THYROIDRadioiodine, doxorubicin & cisplatin
![Page 77: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/77.jpg)
CARCINOMACARCINOMAGASTROINTESTINAL CARCINOMAS• Stomach: 5FU plus cisplatin• Colon: 5 FU + leucoverin + oxiplatin
MALIGNANT MELANOMA & MISC SARCOMAS:–dacarbazine & cisplain
BRAIN TUMORS• > carmustine, multimodality therapy
![Page 78: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/78.jpg)
LUNG CARCINOMALUNG CARCINOMA• Small cell( SCLCa)
• Non-small cell(NSCLCa)75-80%
• CISPLATIN & TAXANES• Others: methotrexate, vincristine,
vinblastine, doxorubicin, mitomycin C
![Page 79: Anti Cancer New Program](https://reader034.vdocuments.site/reader034/viewer/2022052522/554b1c5db4c90562098b5180/html5/thumbnails/79.jpg)
THANK YOU THANK YOU VERY MUCH !!!VERY MUCH !!!
Cast your burden on the Lord.Cast your burden on the Lord.And He shall sustain youAnd He shall sustain youHe shall never permit theHe shall never permit theRighteous to be moved.Righteous to be moved.
Psalm 55 : 22Psalm 55 : 22